This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or refuse these technologies
Medicilon has experienced teams who are experts in drug safety evaluation and can promise high-quality data and fast turnaround times to support various drug safety evaluation. Our toxicology research is carried out using different animals, from dose design, experimental research to histological and pathological research (including clinical detection). The research can be carried out according to non-GLP or GLP standards. Our research platform has been rated as Shanghai R&D Public Service Platform.
In 2008, Shanghai Medicilon Inc. and MPI Research (an American CRO specializing in non-clinical drug safety evaluation services) established a joint venture - Medicilon Preclinical Research. As part of the joint venture, MPI provided the American GLP system and standard operation procedures for research to Medicilon Preclinical Research. Scientists from MPI provided training sessions for Medicilon Preclinical Research employees, and completed many non-clinical drug evaluation research projects with Medicilon scientists and technicians for clients at home and abroad.
As GLP-based laboratories are important for non-clinical drug researches, Medicilon Preclinical Research became one of the early CRO companies that built preclinical animal laboratories in China after following their American peers’ experience. The joint venture has been granted AAALAC Accreditation and GLP certification by NMPA, and meets the FDA’s GLP standards . Medicilon Preclinical Research is qualified for IND services and has been granted AAALAC Accreditation.
GLP certificate
NMPA granted Medicilon Preclinical Research GLP certification in 2011. Its toxicological research data also meets GLP standards of both the FDA and the OECD.
AAALAC
In 2009, the Medicilon’s preclinical research experiment facilities were granted AAALAC Accreditation, and then again in both 2012 and 2016.
Animal rooms
Medicilon Preclinical Research has rooms for the following animals:
Technical Service Platform for Non-human Primate Bio-tech-based Drug Safety Evaluation in ShanghaiTechnical service platform for non-human primate experiment researchDrug discovery and screening platform based on protein crystallographyTechnical service platform for isotope drug metabolism research
Completed projects
Since 2012, Medicilon Preclinical Research has completed over 30 outsourcing services for non-clinical drug safety evaluation and 800 toxicological services. The tests involve micromolecule drugs, bio-tech-based drugs, vaccines (monovalent and multivalent), Chinese medicines, and natural medicines.
Filing of new drugs
Since 2012, Medicilon Preclinical Research has completed nearly 50 complete sets of application materials for GLP toxicology packages, as well as hundreds of individual toxicological studies for non-clinical safety evaluation outsourcing services. The data has been reported to the NMPA, FDA, and TGA to support IND filing.
Download
Sino-foreign joint venture
Relevant laboratories
Relevant articles
marketing@medicilon.com
ABOUT
